Rozanolixizumab (Anti-FcRn (FCGRT & B2M))

Rozanolixizumab (Anti-FcRn (FCGRT & B2M)) is a high-affinity humanized monoclonal antibody, targeting human neonatal Fc receptor (FcRn) and is used to the research of reducing pathogenic IgG in autoimmune and alloimmune diseases. MW: 150 KD.
Supplier Selleck Chemicals
Product # A2500
Sku # A2500-1mg*25
Pricing 1mg*25, $2970.00
Feedback